Sanofi Consumer Healthcare India LimitedSANOFICONRCorporate

Pharmaceuticals - Multinational Latest results: Jun 2026 7 quarters of data

₹3,548.70

MCap ₹8,185 Cr · P/E 30.8

Sanofi Consumer Healthcare India Limited — Stock analysis & AI research Sanofi Consumer Healthcare India Limited — Multibagger AI analysis Sanofi Consumer Healthcare India Limited — Seasonality — best & worst months Sanofi Consumer Healthcare India Limited — Technical indicators & charts Sanofi Consumer Healthcare India Limited — Technical setup — score, trend, support & resistance Sanofi Consumer Healthcare India Limited — Live exchange announcements

📋 High Operating Margin Stocks 📋 High Interest Coverage Stocks 📋 High Promoter Holding Stocks 📈 RSI Oversold Stocks 📈 Lowest Technical Score 📈 Multi-Timeframe Bearish Stocks 📈 Stocks Near 52-Week Low 🏭 Pharma sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹236 Cr

Sales · Jun 2026

+6.7% YoY

₹89 Cr

Operating Profit · Jun 2026

+27.6% YoY

37.9%

OPM % · Jun 2026

+19.6% YoY

₹69 Cr

Net Profit · Jun 2026

+12.8% YoY

₹29.87

EPS · Jun 2026

+13.3% YoY

📝 Sanofi Consumer Healthcare India Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Sanofi Consumer Healthcare India Limited reported revenue of ₹236 crore for the quarter ended June 2026 (Q1 FY27), up 6.7% from ₹221 crore in the same quarter last year, and up 2.9% sequentially over the March 2026 quarter.

Net profit rose 12.8% year-on-year to ₹69 crore, from ₹61 crore. Earnings per share (EPS) came in at ₹29.87.

Operating profit stood at ₹89 crore — an operating margin (OPM) of 37.9%, compared with 31.7% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Sanofi Consumer Healthcare India Limited posted revenue of ₹935 crore, with a net profit of ₹258 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹950 crore with a net profit of ₹266 crore.

Valuation snapshot

At the current price of ₹3,548.70, SANOFICONR has a market capitalisation of ₹8,185 crore and a trailing P/E of about 30.8.

Within the Pharmaceuticals - Multinational industry, it is the 2nd-largest of the 3 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 71.27%, foreign institutional investors (FIIs) 2.60%, domestic institutional investors (DIIs) 17.86%, public shareholders 8.27% of Sanofi Consumer Healthcare India Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹8,185 Cr

Current Price ?

₹3,548.7

P/E ?

30.79above ind

Industry P/E ?

24.10

P/B ?

N/A

P/S ?

8.62

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

3.2%

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

₹950 Cr

OPM ?

37.2%

Profit after tax (TTM) ?

₹266 Cr

EPS (TTM) ?

₹115.25

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹236 Cr

PAT — latest qtr ?

₹69 Cr

YoY qtr sales growth ?

6.7%

YoY qtr profit growth ?

12.8%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

322.0

Current Ratio ?

N/A

Ownership

Promoter holding ?

71.27%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-22.3%

Return 6 months ?

-24.8%

🗓️ Quarterly results (7 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	171	173	221	234	251	229	236	+6.7%	+2.9%
Operating Profit	62	64	70	85	90	89	89	+27.6%	+0.3%
Other Income	2	5	12	3	5	6	6	-47.5%	+5.0%
Interest	0	0	0	1	0	0	0	—	—
Depreciation	1	2	3	3	3	3	3	+10.0%	+10.0%
Profit Before Tax	63	67	79	84	90	91	92	+16.3%	+1.0%
Net Profit	44	50	61	63	66	68	69	+12.8%	+1.2%
EPS	19.24	21.71	26.36	27.31	28.87	29.44	29.87	+13.3%	+1.5%
OPM %	36.3%	37.0%	31.7%	36.3%	35.9%	38.9%	37.9%	+19.6%	-2.6%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	Prev FY	FY26	TTM	YoY %
Sales	—	₹935 Cr	₹950 Cr	—
Operating Profit	—	₹334 Cr	₹353 Cr	—
OPM %	—	35.72%	37.20%	—
NPM %	—	27.59%	27.99%	—
Other Income	—	₹26 Cr	₹20 Cr	—
Depreciation	—	₹12 Cr	₹12 Cr	—
Interest	—	₹1 Cr	₹1 Cr	—
EBIT	—	₹322 Cr	₹341 Cr	—
PBT	—	₹344 Cr	₹357 Cr	—
Tax	—	—	₹23 Cr	—
Net Profit	—	₹258 Cr	₹266 Cr	—
EPS	—	₹111.98	₹115.49	—
Material Cost	—	—	₹64 Cr	—
Employee Cost	—	—	₹31 Cr	—
Extraordinary Items	—	—	—	—

👥 Shareholding (latest 1 periods)

Metric	Jun 2026	% Chg
Promoters	71.27%	—
FIIs	2.60%	—
DIIs	17.86%	—
Public	8.27%	—
No. of Shareholders	47,511	—

⚖️ Peer comparison

Industry: Pharmaceuticals - Multinational · 3 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	PGHL Procter & Gamble	₹5,321.00	8,833	24.7	1,433	358	32.5%	25.0%	15.6%	30.8%	7.3%	45.7%
2	SANOFICONR Sanofi Consumer	₹3,650.00	8,418	31.6	950	266	37.2%	28.0%	—	—	6.7%	12.8%
3	SANOFI Sanofi India	₹2,928.60	6,745	20.8	1,805	324	26.7%	18.0%	16.4%	1.8%	7.8%	19.3%

❓ Frequently asked questions

What was Sanofi Consumer Healthcare India Limited's revenue in Q1 FY27?

What was Sanofi Consumer Healthcare India Limited's net profit in Q1 FY27?